Comparative treatment costs of risk-stratified therapy for childhood acute lymphoblastic leukemia in India.

Tushar MungleNandana DasSaikat PalManash Pratim GogoiParag DasNiharendu GharaDebjani GhoshRamandeep Singh AroraNickhill BhaktaVaskar SahaShekhar Krishnan

Published in: Cancer medicine (2022)

Risk-stratified approach to treat childhood ALL is very cost-effective for all categories in our setting. The cost for SR and IR patients is significantly reduced through decreased IP admissions for both, chemotherapy and non-chemotherapy reasons.

Keyphrases

acute lymphoblastic leukemia
end stage renal disease
newly diagnosed
ejection fraction
locally advanced
chronic kidney disease
peritoneal dialysis
prognostic factors
squamous cell carcinoma
early life
childhood cancer
allogeneic hematopoietic stem cell transplantation
radiation therapy
rectal cancer